ReviewFrontiers in immunology2022
CD47 as a promising therapeutic target in oncology.
Hai Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Hai Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.